Monographs: Dapagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes.
págs. 289-301
Tivozanib: practical implications for renal cell carcinoma and other solid tumors.
págs. 303-315
Meeting report: A report from the 65th annual meeting of the American Academy of Neurology (March 16-23; 2013, San Diego, California, USA)
págs. 341-345
© 2001-2024 Fundación Dialnet · Todos los derechos reservados